CDXS vs BIIB: Which Stock is Better?
Side-by-side comparison of Codexis Inc and Biogen Inc in 2026
CDXS
Codexis Inc
$2.59
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | CDXS | BIIB | Winner |
|---|---|---|---|
| Market Cap | $230.81M | $26.03B | BIIB |
| P/E Ratio | N/A | 20.04 | BIIB |
| EPS (TTM) | $N/A | $8.85 | BIIB |
| Revenue Growth | 0.8% | -0.1% | CDXS |
| Gross Margin | 12.4% | 78.9% | BIIB |
Analyze CDXS
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CDXS or BIIB a better investment?
Comparing CDXS and BIIB: Codexis Inc has a market cap of $230.81M while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CDXS and BIIB?
CDXS (Codexis Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CDXS or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CDXS or BIIB?
CDXS has higher revenue growth at 0.8% vs -0.1% for BIIB.
Which company is more profitable: CDXS or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 12.4% for CDXS.
Which is the larger company: CDXS or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $230.81M for CDXS.
Should I buy CDXS or BIIB in 2026?
Both CDXS and BIIB have investment merit. CDXS trades at $2.59 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CDXS and BIIB stock?
Key differences: Market Cap ($230.81M vs $26.03B), P/E Ratio (N/A vs 20.0x), Revenue Growth (0.8% vs -0.1%), Gross Margin (12.4% vs 78.9%).